Bladder Cancer,Genitourinary Cancer RC48 Alone or With Tislelizumab Shows Promise for NMIBC May 22, 2024
Bladder Cancer,Genitourinary Cancer Efficacy of Nadofaragene Firadenovec in BCG-Unresponsive NMIBC May 10, 2024
Bladder Cancer,Genitourinary Cancer SLC3A2 Impact on BLCA Cells & Tumor-Associated Macrophages Apr 26, 2024
